Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model

Xujiao Zhou(Fudan University), Jihong Wu(Fujian Normal University), Rong Zhang(Guizhou University), Shenghai Zhang(Sun Yat-sen University), Yun Cheng(Shanghai Medical College of Fudan University), Gang Li(Pfizer (United States)), Boqi Yang(Shanghai Medical College of Fudan University)
Scientific Reports
May 5, 2017
10.1038/s41598-017-02092-6
Cited by 32

Related Papers

Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|186
Therapeutic Nanoparticles from Grape Seed for Modulating Oxidative Stress
|Small|2021|109
Neuroendocrine Function After Hypothalamic Depletion of Glucocorticoid Receptors in Male and Female Mice
|Endocrinology|2015|89
Membrane Fusion‐Mediated Loading of Therapeutic siRNA into Exosome for Tissue‐Specific Application
|Advanced Materials|2024|88
Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma
|Journal of Neuroscience|2018|78